Alector (ALEC) Market Capitalization (2019 - 2026)
Alector's (ALEC) quarterly Market Capitalization came in at $224.4 million in Q2 2026, up 58.39% year-over-year from $141.7 million in Q2 2025, and down 5.98% quarter-over-quarter from $238.7 million in Q1 2026.
Analysis
Alector (ALEC) Market Capitalization (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Market Capitalization for 8 consecutive years, with $224.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Market Capitalization rose 58.39% year-over-year to $224.4 million in Q2 2026; TTM through Jun 2026 was $224.4 million, a 58.39% increase from a year earlier, with the FY2025 full-year figure at $172.2 million, down 8.07% from the prior year.
- Market Capitalization was $224.4 million for Q2 2026 at Alector, down from $238.7 million in the prior quarter.
- Over five years, Market Capitalization peaked at $1.2 billion in Q1 2022 and troughed at $123.0 million in Q1 2025.
- A 5-year average of $481.6 million and a median of $480.1 million in 2023 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization sank 78.8% in 2025 and soared 94.08% in 2026, its largest moves.
- Over 5 years, Market Capitalization stood at $765.1 million in 2022, then decreased by 11.47% to $677.3 million in 2023, then plunged by 72.35% to $187.3 million in 2024, then slipped by 8.07% to $172.2 million in 2025, then jumped by 30.36% to $224.4 million in 2026.
- The last three Market Capitalization figures came in at $224.4 million (Q2 2026), $238.7 million (Q1 2026), and $172.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 224.43 Mn |
| Mar 31, 2026 | 238.70 Mn |
| Dec 31, 2025 | 172.17 Mn |
| Sep 30, 2025 | 318.04 Mn |
| Jun 30, 2025 | 141.70 Mn |
| Mar 31, 2025 | 122.99 Mn |
| Dec 31, 2024 | 187.27 Mn |
| Sep 30, 2024 | 456.35 Mn |
| Jun 30, 2024 | 441.84 Mn |
| Mar 31, 2024 | 580.24 Mn |
| Dec 31, 2023 | 677.34 Mn |
| Sep 30, 2023 | 545.20 Mn |
| Jun 30, 2023 | 503.82 Mn |
| Mar 31, 2023 | 515.95 Mn |
| Dec 31, 2022 | 765.13 Mn |
| Sep 30, 2022 | 775.59 Mn |
| Jun 30, 2022 | 832.98 Mn |
| Mar 31, 2022 | 1.17 Bn |
| Dec 31, 2021 | 1.69 Bn |
| Sep 30, 2021 | 1.81 Bn |